![](/img/cover-not-exists.png)
A phase 2 trial of lenvatinib in combination with everolimus in patients with advanced or metastatic non-clear cell renal cell carcinoma
Hutson, T., Xing, D., Dutcus, C., Baig, M., Fishman, M.Volume:
16
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/s1569-9056(17)30280-4
Date:
March, 2017
File:
PDF, 215 KB
english, 2017